Effect of remote ischemic preconditioning in the elderly patients with coronary artery disease with diabetes mellitus undergoing elective drug-eluting stent implantation

Angiology

Volumn 65, Issue 8, 2014, Pages 660-666

  Xu, Xiaohan ^a   Zhou, Yujie ^a   Luo, Shengjie ^a,b   Zhang, Weijun ^a   Zhao, Yingxin ^a   Yu, Miao ^a   Ma, Qian ^a   Gao, Fei ^a   Shen, Hua ^a   Zhang, Jianwei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

diabetes mellitus; drug eluting stent; elderly; high sensitivity cardiac troponin I; myocardial infarction type 4a; remote ischemic preconditioning

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLICLAZIDE; GLIPIZIDE; GLIQUIDONE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; REPAGLINIDE; ROSUVASTATIN; TIROFIBAN; TRIMETAZIDINE; TROPONIN I;

AGED; ARTICLE; CARDIOVASCULAR STENT; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC PRECONDITIONING; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

DIABETES MELLITUS; DRUG-ELUTING STENT; ELDERLY; HIGH SENSITIVITY CARDIAC TROPONIN I; MYOCARDIAL INFARCTION TYPE 4A; REMOTE ISCHEMIC PRECONDITIONING;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CORONARY DISEASE; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84905897849     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713507332     Document Type: Article

References (40)

1. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 ; 60 (16). 1581-1598
2. Porto I, Selvanayagam JB, Van Gaal WJ, et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation. 2006 ; 114 (7). 662-669
3. Bahrmann P, Figulla HR, Wagner M, Ferrari M, Voss A, Werner GS. Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions. Heart. 2005 ; 91 (9). 1186-1192
4. Davies WR, Brown AJ, Watson W, et al. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up. Circ Cardiovasc Interv. 2013 ; 6 (3). 246-251
5. Feldman DN, Kim L, Rene AG, Minutello RM, Bergman G, Wong SC. Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv. 2011 ; 77 (7). 1020-1030
6. Heusch G, Kleinbongard P, Böse D, et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation. 2009 ; 120 (18). 1822-1836
7. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet. 2013 ; 381 (9861). 166-175
8. Standards of medical care in diabetes - 2013. Diabetes Care. 2013 ; 36 (suppl 1). S11 - S66
9. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006 ; 17 (10). 2937-2944
10. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 ; 74 (5). 1124-1136
11. Kharbanda RK, Mortensen UM, White PA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002 ; 106 (23). 2881-2883
12. Tamareille S, Mateus V, Ghaboura N, et al. RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning. Basic Res Cardiol. 2011 ; 106 (6). 1329-1339
13. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res. 2012 ; 110 (1). 111-115
14. Hausenloy DJ, Mwamure PK, Venugopal V, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007 ; 370 (9587). 575-579
15. Iliodromitis EK, Kyrzopoulos S, Paraskevaidis IA, et al. Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning?. Heart. 2006 ; 92 (12). 1821-1826
16. Hoole SP, Heck PM, Sharples L, et al. Cardiac remote ischemic preconditioning in coronary stenting (CRISP stent) study: a prospective, randomized control trial. Circulation. 2009 ; 119 (6). 820-827
17. Bøtker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010 ; 375 (9716). 727-734
18. Rentoukas I, Giannopoulos G, Kaoukis A, et al. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2010 ; 3 (1). 49-55
19. Luo SJ, Zhou YJ, Shi DM, Ge HL, Wang JL, Liu RF. Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation. Can J Cardiol. 2013 ; 29 (9). 1084-1089
20. Ghaemian A, Nouraei SM, Abdollahian F, Naghshvar F, Giussani DA, Nouraei SA. Remote ischemic preconditioning in percutaneous coronary revascularization: a double-blind randomized controlled clinical trial. Asian Cardiovasc Thorac Ann. 2012 ; 20 (5). 548-554
21. Prasad A, Gössl M, Hoyt J, et al. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial. Catheter Cardiovasc Interv. 2013 ; 81 (6). 930-936
22. Ahmed RM, Mohamed EH, Ashraf M, et al Catheter Cardiovasc Interv. 2013 :
23. Brevoord D, Kranke P, Kuijpers M, Weber N, Hollmann M, Preckel B. Remote ischemic conditioning to protect against ischemia-reperfusion injury: a systematic review and meta-analysis. PLoS ONE. 2012 ; 7 (7). e42179
24. Yetgin T, Manintveld OC, Boersma E, et al. Remote ischemic conditioning in percutaneous coronary intervention and coronary artery bypass grafting. Circ J. 2012 ; 76 (10). 2392-2404
25. Alreja G, Bugano D, Lotfi A. Effect of remote ischemic preconditioning on myocardial and renal injury: meta-analysis of randomized controlled trials. J Invasive Cardiol. 2012 ; 24 (2). 42-48
26. Boengler K, Schulz R, Heusch G. Loss of cardioprotection with ageing. Cardiovasc Res. 2009 ; 83 (2). 247-261
27. Przyklenk K. Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum. Drugs Aging. 2011 ; 28 (5). 331-343
28. Murphy E, Steenbergen C. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res. 2007 ; 75 (3). 478-486
29. Mochly-Rosen D, Grimes KV. Myocardial salvage in acute myocardial infarction - challenges in clinical translation. J Mol Cell Cardiol. 2011 ; 51 (4). 451-453
30. Donato M, Buchholz B, Rodríguez M, et al. Role of the parasympathetic nervous system in cardioprotection by remote hindlimb ischaemic preconditioning. Exp Physiol. 2013 ; 98 (2). 425-434
31. Basalay M, Barsukevich V, Mastitskaya S, et al. Remote ischaemic pre- and delayed postconditioning - similar degree of cardioprotection but distinct mechanisms. Exp Physiol. 2012 ; 97 (8). 908-917
32. Mastitskaya S, Marina N, Gourine A, et al. Cardioprotection evoked by remote ischaemic preconditioning is critically dependent on the activity of vagal pre-ganglionic neurones. Cardiovasc Res. 2012 ; 95 (4). 487-494
33. Shimizu M, Tropak M, Diaz RJ, et al. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond). 2009 ; 117 (5). 191-200
34. Hepponstall M, Ignjatovic V, Binos S, et al. Remote ischemic preconditioning (RIPC) modifies plasma proteome in humans. PLoS ONE. 2012 ; 7 (11). e48284
35. Albrecht M, Zitta K, Bein B, et al. Remote ischemic preconditioning regulates HIF-1α levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study. Basic Res Cardiol. 2013 ; 108 (1). 314
36. Whittington HJ, Harding I, Stephenson CI, et al. Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling. Cardiovasc Res. 2013 ; 99 (4). 694-704
37. Oosterlinck W, Dresselaers T, Geldhof V, et al. Diabetes mellitus and the metabolic syndrome do not abolish, but might reduce, the cardioprotective effect of ischemic postconditioning. J Thorac Cardiovasc Surg. 2013 ; 145 (6). 1595-1602
38. Jensen RV, Støttrup NB, Kristiansen SB, Bøtker HE. Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients. Basic Res Cardiol. 2012 ; 107 (5). 285
39. Er F, Nia AM, Dopp H, et al. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro trial (renal protection trial). Circulation. 2012 ; 126 (3). 296-303
40. Zimmerman J, Fromm R, Meyer D, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation. 1999 ; 99 (13). 1671-1677